Clinical Trial Update: Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing photodynamic therapy with Metvix Cream 160 mg/g versus placebo cream in participants with primary nodular basal cell carcinoma has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Metvix Cream 160 mg/g (methyl aminolevulinate)

Snippet

Sponsor: Galderma R&D | Conditions: Basal Cell Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2024-08-05